Genky DrugStores Extends Regional Store Expansion While Sustaining Profit Growth

The latest announcement is out from Genky DrugStores Co., Ltd. ( (JP:9267) ).

Genky DrugStores reported steady expansion of its store network and sales floor, increasing total outlets from 480 to 538 in fiscal 2026 while maintaining a focus on core regional markets. Revenue and gross profit continued to grow at high single‑digit rates, supported by positive same‑store sales and stable gross margins around 20%, as the chain pursued disciplined openings, limited closures and ongoing renovations.

Operating and ordinary profit both rose compared with prior years, with operating margin hovering around the mid‑4% to 5% range despite rising SG&A and labor costs. Earnings per share and book value per share have trended upward alongside improving ROE and equity ratio, indicating that the company is balancing aggressive capital expenditure and depreciation with robust cash generation and manageable leverage, which should reassure equity investors and creditors about its financial health.

More about Genky DrugStores Co., Ltd.

Genky DrugStores Co., Ltd. operates a Japanese drugstore chain focused on pharmaceuticals, daily necessities and food products, expanding primarily through large-format stores in regional markets such as Fukui, Ishikawa, Gifu, Aichi and Shiga prefectures. The company emphasizes high sales efficiency per unit floor area and continues to grow its network while maintaining solid profitability and capital efficiency indicators.

Average Trading Volume: 76,470

Technical Sentiment Signal: Hold

Current Market Cap: Yen118.9B

Find detailed analytics on 9267 stock on TipRanks’ Stock Analysis page.